Advertisements



AbCellera: Second antibody from pact with Eli Lilly enters trials

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallMay 4th, 2021

AbCellera-Lilly Partnered Second COVID-19 Antibody Enters Human Trials

read more.....»»

Category: blogSource: benzingaMay 4th, 2021

AbCellera, Gilead announce new multi-Year, multi-target antibody discovery pact

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallApr 1st, 2021

Biolojic Inks Research And Licensing Pact With Eli Lilly For Diabetes Antibody Therapies

read more.....»»

Category: blogSource: benzingaMar 9th, 2021

Eli Lilly CEO: Developing potential coronavirus treatment at "lightning speed’

Lilly teamed with AbCellera to create an antibody therapy for the coronavirus......»»

Category: topSource: foxnewsMar 27th, 2020

Bio-Techne enters pact with 908 Devices for protein characterization solution

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallMay 4th, 2021

: Lilly’s COVID-19 antibody drugs are a top seller this quarter, but investors aren’t that excited

Eli Lilly's COVID-19 monoclonal antibody treatments brought in $810.1 million in global sales in the first three months of the year, but investors remain largely lukewarm about therapies that they expect to have a short lifespan......»»

Category: topSource: marketwatchApr 27th, 2021

CityCenter enters pact to sell two-acre parcel of land in Las Vegas for $80M

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallApr 26th, 2021

Eli Lilly asks FDA to revoke EUA for COVID antibody treatment alone to speed transition to combination therapy

Eli Lilly and Co. said Friday it is seeking a revocation of the emergency use authorization granted by U.S. regulators for its bamlanivimab antibody treatment for COVID-19 alone in order to complete the transition to bamlanivimab and etesevim.....»»

Category: topSource: marketwatchApr 16th, 2021

AbCellera, Empirico to partner on multi-target antibody discovery

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallApr 14th, 2021

Eli Lilly, Vir and Glaxo announce positive data in Phase 2 trial of COVID antibody treatment

This is a Real-time headline. These are breaking news, delivered the minute it happens, delivered ticker-tape style. Visit www.marketwatch.com or the quote page for more information about this breaking news......»»

Category: topSource: marketwatchMar 29th, 2021

J.M. Smucker enters pact with JDE Peet"s, plans to close Virginia facility

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallMar 24th, 2021

Exelixis enters STELLAR-001 pact, supply agreement with Merck KGaA and Pfizer

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallMar 18th, 2021

Lilly says its monoclonal antibody is no longer being ordered in 3 states due to variant concerns

Shares of Eli Lilly & Co. were up 0.2% in premarket trading on Thursday af.....»»

Category: topSource: marketwatchMar 18th, 2021

FirstEnergy enters pact with Icahn Capital to add two new members to board

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallMar 16th, 2021

: AstraZeneca to supply U.S. with extra 500,000 doses of COVID-19 antibody-based cocktail

AZD7442 is being evaluated for the prevention and treatment of COVID-19 in late-stage trials in more than 9,000 participants around the world......»»

Category: topSource: marketwatchMar 16th, 2021

Lilly shares more data that says its COVID-19 antibody cocktail can cut hospitalizations, deaths

Shares of Eli Lilly & Co. gained 0.7% in premarket trading on Wednesday after the drug maker said its COVID-19 antibody cocktail reduced hospitalizations and deaths in.....»»

Category: topSource: marketwatchMar 10th, 2021

Aridis Pharmaceuticals enters licensing pact with Kermode Biotechnologies

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallMar 8th, 2021

EMA"s Medicinal Committee Backs Eli Lilly"s COVID-19 Antibody Therapy

read more.....»»

Category: blogSource: benzingaMar 5th, 2021

NIH stops clinical trials for two experimental antibody COVID-19 treatments

The National Institutes of Health said Thursday t.....»»

Category: topSource: marketwatchMar 5th, 2021

Eli Lilly awarded $210M Army contract for 100,000 doses of antibody therapeutic

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallFeb 26th, 2021